{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:45:11Z","timestamp":1786113911976,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025HY0069"],"award-info":[{"award-number":["2025HY0069"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQZSZ25H160001"],"award-info":[{"award-number":["LQZSZ25H160001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02067"],"award-info":[{"award-number":["2025C02067"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573495"],"award-info":[{"award-number":["82573495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.canlet.2026.218650","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:38:20Z","timestamp":1780641500000},"page":"218650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GPI promotes immunosuppression in anaplastic thyroid carcinoma via O-GlcNAcylated THBS1-mediated myeloid cell crosstalk"],"prefix":"10.1016","volume":"656","author":[{"given":"Tong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-6418","authenticated-orcid":false,"given":"Minghua","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218650_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218650_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"American thyroid association guidelines for management of patients with anaplastic thyroid cancer, thyroid","volume":"31","author":"Bible","year":"2021","journal-title":"Off. J. Am. Thyroid Assoc."},{"key":"10.1016\/j.canlet.2026.218650_bib3","article-title":"Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma","volume":"6","author":"Wang","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218650_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102614","article-title":"Novel targets for immune-checkpoint inhibition in cancer","volume":"120","author":"Borgeaud","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218650_bib5","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218650_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1078-0432.CCR-21-2182","article-title":"A multicenter phase II trial of ipilimumab and nivolumab in unresectable or metastatic metaplastic breast cancer: cohort 36 of dual Anti-CTLA-4 and Anti-PD-1 blockade in rare tumors (DART, SWOG S1609)","volume":"28","author":"Adams","year":"2022","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218650_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1089\/thy.2022.0073","article-title":"An evaluation of clinical efficacy of immune checkpoint inhibitors for patients with anaplastic thyroid carcinoma, thyroid","volume":"32","author":"Hatashima","year":"2022","journal-title":"Off. J. Am. Thyroid Assoc."},{"key":"10.1016\/j.canlet.2026.218650_bib8","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1038\/s41467-025-58910-3","article-title":"Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers","volume":"16","author":"Pan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218650_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13046-025-03303-z","article-title":"VSIG4(+) tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1","volume":"44","author":"Pan","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.canlet.2026.218650_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166591","article-title":"IL2RA(+)VSIG4(+) tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer, Biochimica et biophysica acta","volume":"1869","author":"Pan","year":"2023","journal-title":"Mol. Basis Disease"},{"key":"10.1016\/j.canlet.2026.218650_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41568-019-0185-x","article-title":"An analysis of genetic heterogeneity in untreated cancers","volume":"19","author":"Reiter","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218650_bib12","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218650_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","article-title":"25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages","volume":"57","author":"Xiao","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218650_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216258","article-title":"O-GlcNAcylation in cancer development and immunotherapy","volume":"566","author":"He","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218650_bib15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","article-title":"High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate","volume":"35","author":"Zhou","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218650_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155804","article-title":"Rhodiolin inhibits the PI3K\/AKT\/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer","volume":"132","author":"Bo","year":"2024","journal-title":"Phytomedicine : Int. J. Phytotherapy Phytopharmacol."},{"key":"10.1016\/j.canlet.2026.218650_bib17","article-title":"Esculetin inhibits liver cancer by targeting glucose-6-phosphate isomerase mediated glycolysis","volume":"188","author":"Hong","year":"2025","journal-title":"Biomed. Pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.canlet.2026.218650_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106995","article-title":"RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32","volume":"198","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218650_bib19","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41467-023-41095-y","article-title":"THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer","volume":"14","author":"Omatsu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218650_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113773","article-title":"THBS1(+) myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1","volume":"43","author":"Giraud","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218650_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094570","article-title":"Functions of Thrombospondin-1 in the tumor microenvironment","volume":"22","author":"Kaur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218650_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218650_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.2012.302","article-title":"A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas","volume":"107","author":"Dom","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218650_bib24","first-page":"5723","article-title":"Genetic expression profile-based screening of genes and pathways associated with papillary thyroid carcinoma","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218650_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13046-023-02751-9","article-title":"ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma","volume":"42","author":"Xu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.canlet.2026.218650_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa161","article-title":"MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm","volume":"22","author":"Bai","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.canlet.2026.218650_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218650_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173712","article-title":"A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer","volume":"9","author":"Han","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2026.218650_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.010","article-title":"The hexosamine biosynthetic pathway and cancer: current knowledge and future therapeutic strategies","volume":"503","author":"Lam","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218650_bib30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2023.02.005","article-title":"Disruption of SLFN11 deficiency-induced CCL2 signaling and macrophage M2 polarization potentiates Anti-PD-1 therapy efficacy in hepatocellular carcinoma","volume":"164","author":"Zhou","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218650_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gutjnl-2024-332901","article-title":"Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages","volume":"74","author":"Lee","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218650_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.10.011","article-title":"Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: a systematic review","volume":"62","author":"R\u00f8ed Sk\u00e5rderud","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218650_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217101","article-title":"O-GlcNAc signaling: implications for stress-induced adaptive response pathway in the tumor microenvironment","volume":"598","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218650_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41419-024-06589-7","article-title":"The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:05:05Z","timestamp":1785960305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0304383526004131"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218650","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPI promotes immunosuppression in anaplastic thyroid carcinoma via O-GlcNAcylated THBS1-mediated myeloid cell crosstalk","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218650"}}